The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Max Kanter, Cofounder & CEO, Feature Labs
P&G Latin America has a common objective of driving an innovation mindset to solve the most important business challenges related to sustainability. This has been declared a priority for the company and its business units in LATAM which have already defined clear strategies and metrics and are looking for innovative solutions to support their vision and goals.
Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.
Startup Lightning Talks, featuring Humatics, Vecna, Woobo, Hydroswarm, Franklin Robotics, GeoScout, Flight Infinity
Vincent Ling, Senior Director, Materials and Innovation, Takeda
Synthetic Biology Workshop 2017 - Panel Discussion